Trupanion Selected By MWI Veterinary Supply as Preferred Provider of Medical Insurance for Cats and Dogs

SEATTLE, Feb. 18, 2015 /PRNewswire/ -- Trupanion, Inc. (NYSE: TRUP) announced today that it was selected by MWI Veterinary Supply, Inc. (Nasdaq: MWIV), a leading distributor of animal health products across the United States of America and United Kingdom, as the preferred provider of medical insurance for cats and dogs for its Distinct Advantage Program members.

The Distinct Advantage Program was designed by MWI to reward and support its best customers. Through MWI's network of more than 300 Territory Managers, Distinct Advantage Members enjoy priority access to a network of trusted animal health products and services.

"MWI is the nation's premier distributor of animal health product and services, serving more than 20,000 customers in North America. Since its founding in 1976, MWI has developed deep relationships with thousands of the nation's leading animal hospitals. We're honored to be selected as their preferred provider of medical insurance for cats and dogs and look forward to leveraging MWI's extensive network to deepen our relationships with Distinct Advantage Program members. Our Territory Partners and Regional Directors will be working side by side with more than 300 MWI Territory Managers to educate member hospitals on the benefits of Trupanion's medical insurance for cats and dogs," said Darryl Rawlings, CEO and Founder of Trupanion.

"After our internal review of the leading companies in the space, we selected Trupanion as the best-in-class of the products on the market. Helping our veterinary customers better understand the value proposition of proactively educating pet owners about medical insurance for their pets will benefit not only pets and veterinary hospitals, but also all companies that sell products and services to the profession," said John Yamagata, Director of National Accounts at MWI.

About MWI

MWI Veterinary Supply, Inc. (MWIV) is a leading distributor of animal health products across the United States of America and United Kingdom. We sell more than 50,000 products, of which over 25,000 are stocked in our distribution centers, sourced from nearly 1,000 vendors. Products we sell include pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, veterinary pet food and nutritional products. We market these products to our customers in both the companion animal and production animal markets, and also offer our customers a variety of value-added services, including on-line ordering via our e-commerce platform, technology management systems, pharmacy fulfillment, inventory management system, equipment procurement consultation and special order fulfillment.

About Trupanion

Trupanion is an industry leader in medical insurance for pets, offering cat and dog medical insurance in the United States, Canada, and Puerto Rico. With over 218,000 total enrolled pets (as of 12/31/2014), Trupanion's mission is to help the pets we all love receive the best veterinary care. Trupanion offers simple, fair and comprehensive pet medical insurance that pays 90% of veterinary costs for pets' covered illness and injury claims that could include diagnostic tests, surgeries, medications, hospital stays, and alternative therapies for the treatment of injuries or illnesses. The Trupanion coverage includes chronic, hereditary and congenital conditions with no payout limits per incident, per year, or over the lifetime of the pet. Some terms and conditions apply; please see our website for details at Trupanion.com

In the United States, Trupanion is underwritten by the American Pet Insurance Company, which has earned a Financial Stability Rating® of A--Exceptional from Demotech, Inc. In Canada, Trupanion is underwritten by Omega General Insurance Company. Trupanion is a founding member of the North American Pet Health Insurance Association (NAPHIA), demonstrating a commitment to high standards and transparency in all actions and products. Trupanion's shares are traded on the New York Stock Exchange under the ticker symbol TRUP.

Contacts:

Investors:
Laura Bainbridge, Kimberly Esterkin, Addo Communications
310.829.5400
[email protected]

Media:
Britta Gidican, Director, Public Relations
[email protected]
206.607.1930

Logo - http://photos.prnewswire.com/prnh/20141030/155651LOGO

 

SOURCE Trupanion

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…